Skip to Main Content

Author Details

Maciej Kwiatkowski
University of Basel, Academic Hospital Braunschweig
1998
67
24
PMIDPaper TitleJournal TitlePublished Year
37088597Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer.Eur Urol2023
34350895Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies.Urol Int2022
35347412Variation across operating sites in urinary and sexual outcomes after radical prostatectomy in localized and locally advanced prostate cancer.World J Urol2022
35012889A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14.Eur Urol Oncol2022
33125581Efficacy, safety, and perioperative outcomes of holmium laser enucleation of the prostate-a comparison of patients with lower urinary tract symptoms and urinary retention.Lasers Med Sci2021
33563084Impact of cancer screening on metastasis: A prostate cancer case study.J Med Screen2021
34934964Intervention-related Deaths in the European Randomized Study of Screening for Prostate Cancer.Eur Urol Open Sci2021
34642448Diagnostic accuracy and clinical implications of robotic assisted MRI-US fusion guided target saturation biopsy of the prostate.Sci Rep2021
31865534Influence of regular aspirin intake on PSA values, prostate cancer incidence and overall survival in a prospective screening trial (ERSPC Aarau).World J Urol2020
31896767Feasibility of freehand MRI/US cognitive fusion transperineal biopsy of the prostate in local anaesthesia as in-office procedure-experience with 400 patients.Prostate Cancer Prostatic Dis2020
30514142Primary urethral squamous cell carcinoma: a unique manifestation of a penile tumor.J Int Med Res2019
30828548Renal pseudoaneuryms and pulmonary embolism: A unique manifestation of complications following blunt renal trauma.Urol Case Rep2019
30824296A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer.Eur Urol2019
30928162Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?Eur Urol2019
29211316The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials.Cancer2018
30211009Single-system orthotopic ureterocele with calculus masquerading as a bladder tumour - A case report and review of literature.Urol Case Rep2018
30510835Ureteral Rupture Caused by Accidental Intubation of the Ureter with a Foley-Catheter during Ureterorenoscopy.Case Rep Urol2018
27855442Impact of cause of death adjudication on the results of the European prostate cancer screening trial.Br J Cancer2017
28376164Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.J Natl Cancer Inst2017
28869989Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.Ann Intern Med2017
27104278Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC).BJU Int2016
26332304A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau).BJU Int2016
26289069Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening.Clin Cancer Res2016
27459245Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis.Cancer2016
26767519Limitations of Elastography Based Prostate Biopsy.J Urol2016
24794075A "PSA pyramid" for men with initial prostate-specific antigen ⿤3 ng/ml: a plea for individualized prostate cancer screening.Eur Urol2015
25633871Differences among men on active surveillance for very low-risk prostate cancer detected through population-based versus opportunistic prostate-specific antigen-screening.Urol Int2015
25791513Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer.Eur Urol2015
25565393Is further screening of men with baseline PSA⿿<⿿1 ng ml(-1) worthwhile? The discussion continues-Results of the Swiss ERSPC (Aarau).Int J Cancer2015
25532573Prostate cancer screening: and yet it moves!Asian J Androl2015
25358675Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau).World J Urol2015
23712424[PSA screening 2013: background and perspectives].Urologe A2014
25505238Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.J Natl Cancer Inst2014
25108889Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.Lancet2014
24820259A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral center.World J Urol2014
24412230A different method of evaluation of the ERSPC trial confirms that prostate-specific antigen testing has a significant impact on prostate cancer mortality.Eur Urol2014
22093744Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol-based active surveillance: results from a contemporary European patient cohort.BJU Int2012
22704366Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).Eur Urol2012
22770614Protocol-based active surveillance for low-risk prostate cancer: anxiety levels in both men and their partners.Urology2012
22894572Quality-of-life effects of prostate-specific antigen screening.N Engl J Med2012
22874102Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer.Epigenetics2012
22285762Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer.Eur Urol2012
22417251Prostate-cancer mortality at 11 years of follow-up.N Engl J Med2012
19739124The effect of study arm on prostate cancer treatment in the large screening trial ERSPC.Int J Cancer2010
21047590Change of tumour characteristics and treatment over time in both arms of the European Randomized study of Screening for Prostate Cancer.Eur J Cancer2010
21047586PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer.Eur J Cancer2010
20967984[Standardization of the laboratory test for PSA].Urologiia2010
19297566Screening and prostate-cancer mortality in a randomized European study.N Engl J Med2009
19660851Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).Eur Urol2009
18560799[Status of care for prostate cancer in 2008].Urologe A2008
  • 1 - 50 of 67

Recommended Authors

Giorgio Gandaglia
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Career Start Year 2012
Number of shared co-authors 7
Francesco Pellegrino
Urological Research Institute, IRCCS San Raffaele Hospital
Career Start Year 2012
Number of shared co-authors 3
Jeffrey J Tosoian
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 3
Michael A Liss
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 3
Alastair D Lamb
University of Oxford
Career Start Year 2007
Number of shared co-authors 7
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2005
Number of shared co-authors 8
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Career Start Year 2004
Number of shared co-authors 11
Ashley E Ross
Northwestern University
Career Start Year 2003
Number of shared co-authors 4
Alberto Briganti
IRCCS San Raffaele Scientific Institute
Career Start Year 2002
Number of shared co-authors 7
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 3
John K Parsons
university of california san diego Moores Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Robert Jeffrey Karnes
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 5
Vincent J Gnanapragasam
University of Cambridge
Career Start Year 1999
Number of shared co-authors 6
Todd M Morgan
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 4
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 7
Stephen J Freedland
Cedars-Sinai Medical Center
Career Start Year 1996
Number of shared co-authors 10
Inge M van Oort
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 5
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 1993
Number of shared co-authors 16
Byung Ha Chung
Yonsei University College of Medicine and Gangnam Severance Hospital
Career Start Year 1992
Number of shared co-authors 1
Nicolas Mottet
Hospitalier Universitaire de Saint-Etienne
Career Start Year 1989
Number of shared co-authors 5
Philip Cornford
Liverpool University Hospitals
Career Start Year 1988
Number of shared co-authors 4
Mark Frydenberg
Monash University
Career Start Year 1988
Number of shared co-authors 9
Freddie C Hamdy
University of Oxford
Career Start Year 1987
Number of shared co-authors 11
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 11
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 7
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 2
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 7
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 8
David E Neal
University of Oxford, John Radcliffe Hospital
Career Start Year 1981
Number of shared co-authors 11
Ian M Thompson
CHRISTUS Santa Rosa Hospital-Medical Center
Career Start Year 1956
Number of shared co-authors 4

Collaborators

Franz Recker
PolyClinic St. Moritz/Scuol
Co-authored papers 41
Monique J Roobol
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 24
Marco Randazzo
Winterthur Cantonal Hospital
Co-authored papers 13
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 6
Sebastiaan Remmers
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 3
Christine D Berg
Co-authored papers 2
Ekaterina Olkhov-Mitsel
University of Toronto
Co-authored papers 2
Laurent Briollais
Institute of Health Policy, Dalla Lana School of Public Health, University of Toronto
Co-authored papers 2
Bharati Bapat
Mt Sinai Hospital
Co-authored papers 2
Eleftherios P Diamandis
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 2
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 2
Neil E Fleshner
University of Toronto
Co-authored papers 2
Hilmi Ozcelik
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 2
Emily D Crawford
Co-authored papers 2
Markus Graefen
University Hospital Frankfurt, Goethe University Frankfurt am Main
Co-authored papers 2
Gerald L Andriole
Co-authored papers 2
John Trachtenberg
University of Toronto, University Health Network
Co-authored papers 1
Antoninus Soosaipillai
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 1
Robert G Bristow
University of Toronto
Co-authored papers 1
Karen Chadwick
University Health Network, University of Toronto
Co-authored papers 1
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Co-authored papers 1
Matt Friedlander
Ontario Institute for Cancer Research
Co-authored papers 1
Angelika Hammerer-Lercher
Co-authored papers 1
Dorota H Sendorek
Ontario Institute for Cancer Research
Co-authored papers 1
Hong Li
Qingdao Hospital of Traditional Chinese Medicine, Qingdao Haici Hospital
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Ewout W Steyerberg
Leiden University Medical Center
Co-authored papers 1
Christine Massey
Princess Margaret Cancer Centre
Co-authored papers 1
Ioannis Prassas
Mount Sinai Hospital
Co-authored papers 1
Sally Hanna
Mount Sinai Hospital
Co-authored papers 1
Release 1.2